1. Home
  2. SNT vs VNRX Comparison

SNT vs VNRX Comparison

Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNT
  • VNRX
  • Stock Information
  • Founded
  • SNT 1965
  • VNRX N/A
  • Country
  • SNT Canada
  • VNRX United States
  • Employees
  • SNT N/A
  • VNRX N/A
  • Industry
  • SNT Telecommunications Equipment
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SNT Telecommunications
  • VNRX Health Care
  • Exchange
  • SNT Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • SNT 64.6M
  • VNRX 67.2M
  • IPO Year
  • SNT 1993
  • VNRX N/A
  • Fundamental
  • Price
  • SNT $3.45
  • VNRX $0.64
  • Analyst Decision
  • SNT
  • VNRX Strong Buy
  • Analyst Count
  • SNT 0
  • VNRX 4
  • Target Price
  • SNT N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • SNT 73.4K
  • VNRX 524.2K
  • Earning Date
  • SNT 11-12-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • SNT N/A
  • VNRX N/A
  • EPS Growth
  • SNT N/A
  • VNRX N/A
  • EPS
  • SNT 0.06
  • VNRX N/A
  • Revenue
  • SNT $34,455,000.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • SNT N/A
  • VNRX $180.66
  • Revenue Next Year
  • SNT N/A
  • VNRX $558.69
  • P/E Ratio
  • SNT $54.86
  • VNRX N/A
  • Revenue Growth
  • SNT 2.04
  • VNRX 97.50
  • 52 Week Low
  • SNT $1.08
  • VNRX $0.43
  • 52 Week High
  • SNT $3.35
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • SNT 71.93
  • VNRX 49.57
  • Support Level
  • SNT $2.90
  • VNRX $0.57
  • Resistance Level
  • SNT $3.09
  • VNRX $0.68
  • Average True Range (ATR)
  • SNT 0.19
  • VNRX 0.08
  • MACD
  • SNT 0.00
  • VNRX -0.00
  • Stochastic Oscillator
  • SNT 98.16
  • VNRX 58.40

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: